Recruiting
Phase 1

IL-8R-modified CAR T

Sponsor:

University of Florida

Code:

NCT06946680

Conditions

High-grade Glioma

Eligibility Criteria

Sex: All

Age: 4 - 18

Healthy Volunteers: Not accepted

Interventions

Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-14. This information was provided to ClinicalTrials.gov by University of Florida on 2025-09-16.